561 related articles for article (PubMed ID: 33506944)
1. Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience.
De Vito A; Geremia N; Princic E; Fanelli C; Panu Napodano CM; Muredda AA; Fiore V; Maida I; Fois AG; Babudieri S; Madeddu G
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):523-526. PubMed ID: 33506944
[TBL] [Abstract][Full Text] [Related]
2. Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes.
De Vito A; Fiore V; Princic E; Geremia N; Panu Napodano CM; Muredda AA; Maida I; Madeddu G; Babudieri S
PLoS One; 2021; 16(3):e0248009. PubMed ID: 33724987
[TBL] [Abstract][Full Text] [Related]
3. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
4. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.
Bravi F; Flacco ME; Carradori T; Volta CA; Cosenza G; De Togni A; Acuti Martellucci C; Parruti G; Mantovani L; Manzoli L
PLoS One; 2020; 15(6):e0235248. PubMed ID: 32579597
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada.
Campitelli MA; Bronskill SE; Maclagan LC; Harris DA; Cotton CA; Tadrous M; Gruneir A; Hogan DB; Maxwell CJ
JAMA Netw Open; 2021 Aug; 4(8):e2118441. PubMed ID: 34338794
[TBL] [Abstract][Full Text] [Related]
7. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
Talreja H; Tan J; Dawes M; Supershad S; Rabindranath K; Fisher J; Valappil S; van der Merwe V; Wong L; van der Merwe W; Paton J
N Z Med J; 2020 Apr; 133(1512):85-87. PubMed ID: 32242182
[TBL] [Abstract][Full Text] [Related]
8. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
9. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M
J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 infections in the Friuli Venezia Giulia Region (Northern Italy): a population-based retrospective analysis.
Calagnan E; Gobbato M; Burba I; Del Zotto S; Toffolutti F; Serraino D; Tonutti G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):323-329. PubMed ID: 33412825
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis.
Christiansen CF; Pottegård A; Heide-Jørgensen U; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Lund LC; Reilev M; Hallas J; Voldstedlund M; Husby A; Thomsen MK; Johansen NB; Brun NC; Thomsen RW; Bøtker HE; Sørensen HT
Thorax; 2021 Apr; 76(4):370-379. PubMed ID: 33293279
[TBL] [Abstract][Full Text] [Related]
12. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.
Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW
J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607
[TBL] [Abstract][Full Text] [Related]
13. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
Reynolds HR; Adhikari S; Pulgarin C; Troxel AB; Iturrate E; Johnson SB; Hausvater A; Newman JD; Berger JS; Bangalore S; Katz SD; Fishman GI; Kunichoff D; Chen Y; Ogedegbe G; Hochman JS
N Engl J Med; 2020 Jun; 382(25):2441-2448. PubMed ID: 32356628
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for outbreaks of SARS-CoV-2 infection at retirement homes in Ontario, Canada: a population-level cohort study.
Costa AP; Manis DR; Jones A; Stall NM; Brown KA; Boscart V; Castellino A; Heckman GA; Hillmer MP; Ma C; Pham P; Rais S; Sinha SK; Poss JW
CMAJ; 2021 May; 193(19):E672-E680. PubMed ID: 33972220
[TBL] [Abstract][Full Text] [Related]
15. Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia.
Georges JL; Gilles F; Cochet H; Bertrand A; De Tournemire M; Monguillon V; Pasqualini M; Prevot A; Roger G; Saba J; Soltani J; Koukabi-Fradelizi M; Beressi JP; Laureana C; Prost JF; Livarek B
PLoS One; 2020; 15(12):e0244349. PubMed ID: 33347477
[TBL] [Abstract][Full Text] [Related]
16. Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
Selçuk M; Çınar T; Keskin M; Çiçek V; Kılıç Ş; Kenan B; Doğan S; Asal S; Günay N; Yıldırım E; Keskin Ü; Orhan AL
Clin Exp Hypertens; 2020 Nov; 42(8):738-742. PubMed ID: 32569491
[TBL] [Abstract][Full Text] [Related]
17. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
Vázquez-Cornejo E
Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
[TBL] [Abstract][Full Text] [Related]
18. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.
Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814
[TBL] [Abstract][Full Text] [Related]
19. Relationship between angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and SARS-CoV-2 infection: where are we?
Infusino F; Cimino S; Lombardi M; Mancone M; Cavarretta E; Frati G; Pugliese F; Fedele F; Biondi Zoccai G
Minerva Cardioangiol; 2020 Aug; 68(4):339-346. PubMed ID: 32472989
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
Pathak JV; Dass EE
Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
